Heartland Advisors Inc. Purchases Shares of 211,848 Teleflex Incorporated $TFX

Heartland Advisors Inc. purchased a new stake in shares of Teleflex Incorporated (NYSE:TFX) in the second quarter, according to its most recent 13F filing with the SEC. The fund purchased 211,848 shares of the medical technology company’s stock, valued at approximately $26,854,000. Teleflex makes up 1.2% of Heartland Advisors Inc.’s investment portfolio, making the stock its 7th largest position.

Other institutional investors have also recently made changes to their positions in the company. Kelleher Financial Advisors purchased a new stake in shares of Teleflex in the second quarter worth $25,000. Banque Cantonale Vaudoise boosted its stake in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the period. UMB Bank n.a. grew its position in Teleflex by 57.1% during the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after buying an additional 113 shares in the last quarter. Allworth Financial LP purchased a new position in Teleflex during the second quarter worth about $44,000. Finally, Kestra Advisory Services LLC bought a new position in Teleflex in the 4th quarter worth about $45,000. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

TFX opened at $138.99 on Friday. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. The stock has a market capitalization of $5.89 billion, a P/E ratio of -5.97, a PEG ratio of 0.90 and a beta of 0.81. The stock has a 50-day moving average price of $132.70 and a 200-day moving average price of $124.73. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $145.00.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.48. The company had revenue of $570.33 million for the quarter, compared to analysts’ expectations of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.Teleflex’s revenue for the quarter was up 28.9% compared to the same quarter last year. During the same period last year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Equities analysts predict that Teleflex Incorporated will post 7.26 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex’s payout ratio is presently -5.84%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on TFX shares. UBS Group lifted their price target on Teleflex from $145.00 to $158.00 and gave the company a “neutral” rating in a research report on Tuesday, August 11th. Needham & Company LLC raised their target price on shares of Teleflex from $147.00 to $159.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Zacks Research upgraded shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Mizuho boosted their price target on shares of Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Finally, Truist Financial increased their price target on shares of Teleflex from $143.00 to $150.00 and gave the stock a “hold” rating in a report on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $151.80.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.